Abstracts: Major Depressive Disorder
Major Depressive Disorder
- A Pooled Analysis of the Effects of Desvenlafaxine Succinate on Symptoms of Anxiety in Patients with Major Depressive Disorder
- Advances in the treatment of depression
- Altered Expression of Phosphodiasterase 4 (PDE4) Variants in Brain of Depressed Subjects: Role in Disease and Treatment
- Evaluation of the Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in Patients With Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
- Gene-environment interactions and exon-specific dysregulation of BDNF expression in a transgenic mouse model of depression-like behaviours
- Need for etiological classification of depressions
- Pathways of risk for depression: BDNFVal66Met, stress and emotional brain systems
- Plasma Melatonin Circadian Rhythms in Pregnancy and Postpartum Depression
- Prevention of Relapse and Recurrence in Affective Disorders
- Relationship of Monoamine Oxidase A Binding Abnormalities to the Development and Maintenance of Major Depressive Disorder
- Role of BDNF in behaviour: studies in rats and BDNF mutant mice
- Role of HPA Axis and Cytokines in Adolescent Depression and Suicide: A Postmortem Brain Study
- The involvement of neurotransmitter receptors and pro-inflammatory pathways in depression
13 abstracts